Despite a surge in June renewable fuel credit generation, tightening supply and persistent compliance pressures point to higher RIN prices ahead of the March 2027 deadline.
Biopharmaceutical innovation has traditionally been difficult to capture through market exposures. This article explores how the Bloomberg Global Innovative Biopharma Index (BGIBT) can help track value creation across the biopharma ecosystem.
The financial industry faces evolving regulations and government expectations in the push to advance the green transition. Green finance policy updates below highlight regulatory and policy insights available to Bloomberg Terminal subscribers.
Recent periods of financial stress and the proliferation of risks across the financial system are fueling the development of regulatory initiatives to strengthen requirements and promote international best practice.
